Patents Assigned to Medigene AG
  • Recombinant AAV vector-based transduction system and use of same
    Patent number: 6440742
    Abstract: The present invention relates to a transduction system, comprising (a) a rep-negative AAV vector containing a foreign DNA and (b) a product providing an AAV Rep protein. The invention also relates to the use of the transduction system.
    Type: Grant
    Filed: January 30, 2001
    Date of Patent: August 27, 2002
    Assignee: Medigene, AG
    Inventors: Gerd Maass, Christoph Bogedain, Michael Hallek, Clemens Wendtner, Doris Michl
  • System for the production of AAV vectors
    Publication number: 20020081709
    Abstract: The invention concern a system comprising an AAV vector, which contains a foreign DNA, and rep 68/78 sequences of AAV with delayed expression, these sequences being present (a) in cis or (b) in trans.
    Type: Application
    Filed: July 18, 2001
    Publication date: June 27, 2002
    Applicant: MEDIGENE AG.
    Inventors: Christoph Bogedain, Gerd Maass, Michael Hallek
  • Papilloma virus capsomere vaccine formulations and methods of use
    Publication number: 20020039584
    Abstract: Vaccine formulations comprising viral capsomeres are disclosed along with methods for their production. Therapeutic and prophylactic methods of use for the vaccine formulations are also disclosed.
    Type: Application
    Filed: March 30, 2001
    Publication date: April 4, 2002
    Applicant: Medigene AG
    Inventors: Michael Hallek, Alexander Burger
  • Papillomavirus truncated L1 protein and fusion protein constructs
    Patent number: 6352696
    Abstract: Vaccine formulations comprising viral capsomeres are disclosed along with methods for their production. Therapeutic and prophylactic methods of use for the vaccine formulations are also disclosed.
    Type: Grant
    Filed: March 30, 2001
    Date of Patent: March 5, 2002
    Assignee: Medigene AG
    Inventors: Michael Hallek, Alexander Burger
  • System for the production of AAV vectors
    Patent number: 6294370
    Abstract: The invention concerns a system comprising an AAV vector, which contains a foreign DNA, and rep 68/78 sequences of AAV with delayed expression, these sequences being present (a) in cis or (b) in trans. The invention also concerns the use of such a system for the production of AAV vectors.
    Type: Grant
    Filed: August 6, 1999
    Date of Patent: September 25, 2001
    Assignee: Medigene AG
    Inventors: Christoph Bogedain, Gerd Maass, Michael Hallek
  • Recombinant AAV vector-based transduction system and use of same
    Patent number: 6207453
    Abstract: The present invention relates to a transduction system, comprising (a) a rep-negative AAV vector containing a foreign DNA and (b) a product providing an AAV Rep protein. The invention also relates to the use of the transduction system.
    Type: Grant
    Filed: May 5, 1999
    Date of Patent: March 27, 2001
    Assignee: Medigene AG
    Inventors: Gerd Maass, Christoph Bogedain, Michael Hallek, Clemens Wendtner, Doris Michl
  • Adeno-associated virus vector for boosting immunogenicity of freshly isolated tumor cells
    Patent number: 6171597
    Abstract: The present invention provides an AAV vector having a foreign DNA coding for a protein that boosts immunogenicity of cells. The invention also provides a vaccine containing such a vector and the use of both.
    Type: Grant
    Filed: May 5, 1999
    Date of Patent: January 9, 2001
    Assignee: Medigene AG
    Inventors: Gerhard Maass, Michael Hallek, Christoph Bogedain